Springfield, MO

Log in Subscribe

AbbVie to buy Allergan for $63B

Posted online

AbbVie signed on to buy rival drugmaker Allergan for $63 billion.

The bid values Allergan's shares at a 45% premium.

The acquisition would combine AbbVie, the maker of arthritis drug Humira, and Allergan, which is known for its wrinkle treatment Botox, among other products.

Read more from Bloomberg.


No comments on this story |
Please log in to add your comment
Editors' Pick
Springfield’s rental picture marked by complexity

Developers say city needs a variety of housing types to meet demand.

Most Read Poll
What kind of housing does Springfield need more of?


View results

Update cookies preferences